MetLife, Inc.
MET
$83.06
$1.501.84%
Weiss Ratings | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Excellent | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Reward Grade | A- | |||
Rating Factors | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Good | |||
Growth Index | Fair | |||
Efficiency Index | Good | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.03 | |||
Price History | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 1.05% | |||
30-Day Total Return | -2.53% | |||
60-Day Total Return | -2.67% | |||
90-Day Total Return | 0.05% | |||
Year to Date Total Return | 2.21% | |||
1-Year Total Return | 20.37% | |||
2-Year Total Return | 27.00% | |||
3-Year Total Return | 47.06% | |||
5-Year Total Return | 151.36% | |||
52-Week High % Change | -6.73% | |||
52-Week Low % Change | 23.42% | |||
Price | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $89.05 | |||
52-Week Low Price | $67.30 | |||
52-Week Low Price (Date) | Aug 05, 2024 | |||
52-Week High Price (Date) | Nov 27, 2024 | |||
Valuation | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 56.58B | |||
Enterprise Value | 101.43B | |||
Price/Earnings (TTM) | 13.92 | |||
Earnings Per Share (TTM) | 5.97 | |||
Earnings Per Share Growth | 226.36% | |||
Price/Earnings To Growth | 0.06 | |||
Price/Sales (TTM) | 0.82 | |||
Price/Book (Q) | 2.09 | |||
Enterprise Value/Revenue (TTM) | 1.43 | |||
Price | $83.06 | |||
Enterprise Value/EBITDA (TTM) | 16.21 | |||
Enterprise Value/EBIT | 18.29 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 697.90M | |||
Dividend Yield | 2.62% | |||
Div. Per Share (Most Recent) | $0.55 | |||
Dividend Per Share (TTM) | $2.18 | |||
Payout Ratio (TTM) | 39.02% | |||
Dividend Per Share (Most Recent) | $0.55 | |||
Company Info | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 212 578 9500 | |||
Address | 200 Park Avenue New York, NY 10166-0188 | |||
Website | www.metlife.com | |||
Country | United States | |||
Year Founded | 1999 | |||
Profitability | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 7.81% | |||
Profit Margin | 6.23% | |||
Management Effectiveness | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 0.51% | |||
Return on Equity | 15.34% | |||
Income Statement | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 70.05B | |||
Total Revenue (TTM) | 70.98B | |||
Revenue Per Share | $101.71 | |||
Gross Profit (TTM) | 17.53B | |||
EBITDA (TTM) | 6.26B | |||
EBIT (TTM) | 5.55B | |||
Net Income (TTM) | 4.43B | |||
Net Income Avl. to Common (TTM) | 4.23B | |||
Total Revenue Growth (Q YOY) | -1.90% | |||
Earnings Growth (Q YOY) | 107.65% | |||
EPS Diluted (TTM) | 5.97 | |||
EPS Diluted Growth (Q YOY) | 130.72% | |||
Balance Sheet | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 28.23B | |||
Cash Per Share (Q) | $40.45 | |||
Total Current Assets (Q) | 71.57B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 27.70B | |||
Current Ratio (Q) | 1.543 | |||
Book Value Per Share (Q) | $39.82 | |||
Total Assets (Q) | 677.46B | |||
Total Current Liabilities (Q) | 46.38B | |||
Total Debt (Q) | 64.66B | |||
Total Liabilities (Q) | 649.75B | |||
Total Common Equity (Q) | 27.45B | |||
Cash Flow | MET - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -11.49B | |||
Cash from Financing (TTM) | -3.13B | |||
Net Change in Cash (TTM) | -571.00M | |||
Levered Free Cash Flow (TTM) | 2.85B | |||
Cash from Operations (TTM) | 14.60B | |||